We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

QR-Bromocriptine as an Adjunct to Insulin and Metformin in the Treatment of Type 2 Diabetes

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01474018
Recruitment Status : Completed
First Posted : November 17, 2011
Last Update Posted : May 22, 2014
Information provided by (Responsible Party):
University of Texas Southwestern Medical Center

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : May 2012
  Study Completion Date : June 2012